Laura Fugazzola
Overview
Explore the profile of Laura Fugazzola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
3901
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Colombo C, De Leo S, Campisi I, Palesandro E, Turco F, Buttigliero C, et al.
Crit Rev Oncol Hematol
. 2025 Feb;
209:104627.
PMID: 39922397
Nowadays immune-based combinations are the standard first-line treatment for metastatic renal cell carcinoma and involve the use of either two immunotherapy agents or an immunotherapeutic drug associated with a tyrosine...
2.
TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer
Cirello V, Colombo C, Tosi D, Manzo A, Borghi M, Gianelli U, et al.
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39891677
Context: No data are available about the possible association of TP53 mutations and the response to multikinase inhibitors (MKIs) in thyroid cancer (TC). Objective: We evaluated the impact of TP53...
3.
Barbieri D, Indelicato P, De Leo S, Moneta C, Coccia S, Gazzano G, et al.
Updates Surg
. 2025 Jan;
PMID: 39825021
Background: Recently, several devices exploiting the near-infrared autofluorescence (NIR-AF) of parathyroid glands (PGs) have been developed. Nevertheless, their impact on both preserving PGs from inadvertent surgical dissection and on post-surgical...
4.
Campi I, Fugazzola L
J Endocrinol Invest
. 2024 Oct;
48(2):299-302.
PMID: 39373963
Purpose: We previously showed that the rapid TSH (rTSH) screening is able to detect a high prevalence of thyroid diseases in patients presenting to the Emergency department (ED), with a...
5.
Rotondi M, Endo M, Teliti M, Crescenzi A, Azaryan I, Croce L, et al.
J Clin Endocrinol Metab
. 2024 Oct;
110(3):e907-e910.
PMID: 39353065
Fine-needle-aspiration-cytology (FNAC) is safe and cost-effective procedure for evaluating thyroid nodules. The non-negligible rate of indeterminate thyroid nodule (ITN) cytology warrants diagnostic surgery for histological assessment, in some cases. Two...
6.
Rodrigues J, Chenlo M, Bravo S, Perez-Romero S, Suarez-Farina M, Sobrino T, et al.
Nat Commun
. 2024 Jul;
15(1):5835.
PMID: 38992026
No abstract available.
7.
Ghiandai V, Grassi E, Gazzano G, Fugazzola L, Persani L
Cancer Cell Int
. 2024 Jun;
24(1):196.
PMID: 38835027
Background: Thyroid cancer (TC) is the most common endocrine malignancy. Nowadays, undifferentiated thyroid cancers (UTCs) are still lethal, mostly due to the insurgence of therapy resistance and disease relapse. These...
8.
Rodrigues J, Chenlo M, Bravo S, Perez-Romero S, Suarez-Farina M, Sobrino T, et al.
Nat Commun
. 2024 May;
15(1):3736.
PMID: 38744818
The E3 SUMO ligase PIAS2 is expressed at high levels in differentiated papillary thyroid carcinomas but at low levels in anaplastic thyroid carcinomas (ATC), an undifferentiated cancer with high mortality....
9.
Muzza M, Pogliaghi G, Colombo C, Grassi E, Carbone E, Palazzo S, et al.
Transl Res
. 2024 Apr;
271:1-12.
PMID: 38670453
The reactivation of TERT is associated with poor outcome in papillary thyroid cancer (PTC). Extra-telomeric functions of TERT were reported, with a protective role against oxidative stress (OS). The aim...
10.
Cirello V, Lugaresi M, Moneta C, Dufour P, Manzo A, Carbone E, et al.
Eur Thyroid J
. 2024 Apr;
13(3).
PMID: 38657654
Objective: The aim was to evaluate the possible association between some endocrine disruptive chemicals and thyroid cancer (TC) in an Italian case-control cohort. Methods: We enrolled 112 TC patients and...